$3.6M for Biocept

3/30/10Follow @xconomy

Biocept, a San Diego biotech company working on cell separation technology, has raised $3.6 million of a planned $4.05 million equity offering, according to an SEC filing. Four investors participated in the round for Biocept, which is developing diagnostic assays for detecting and monitoring cancer.

By posting a comment, you agree to our terms and conditions.